Factors predicting in-hospital mortality among patients admitted with community acquired pneumonia at a tertiary care hospital Karachi, Pakistan.


Journal

The clinical respiratory journal
ISSN: 1752-699X
Titre abrégé: Clin Respir J
Pays: England
ID NLM: 101315570

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 06 12 2018
revised: 13 03 2019
accepted: 04 12 2019
pubmed: 22 12 2019
medline: 28 1 2021
entrez: 22 12 2019
Statut: ppublish

Résumé

Community Acquired Pneumonia (CAP) is associated with significant morbidity and mortality globally, but unfortunately there is limited data available from South East Asia. To determine the risk factors associated with in-hospital mortality in patients with CAP in a tertiary care hospital of Pakistan. A retrospective study was conducted on adult patients admitted with a diagnosis of CAP from January 2011 till December 2016. Their clinical records were reviewed and a multivariable analysis was done to determine the factors associated with in-hospital mortality. A total of 1100 files were reviewed, of which 509 were included in the analysis. The mean age was 63.6 ± 16.5 years and 302 (52.16%) were males. The most Common isolated pathogen was Staphylococcus aureus (23%). Overall mortality was 10.8%. On univariate analysis factors associated with mortality were old age patients (P = 0.02); history of pneumonia in last 12 months (P = 0.008); CURB 65 score ≥ 3 (P < 0.001) and high dependency units as initial site of care (P < 0.001). On multivariable analysis CURB65 ≥ 3 score; high dependency unit as initial site of care; bedridden status; presence of bilateral infiltrates on chest X-ray and hemoglobin of 10.4 g/dL or less at the time of admission were key determinants of in-hospital mortality. We found CURB65 ≥ 3 score; high dependency unit as initial site of care; bedridden status; bilateral infiltrates on chest X-ray and low hemoglobin (10.4 g/dL or less) at the time of admission as independent risk factors of in-hospital mortality. Staphylococcus aureus was the most common organism isolated in patients.

Identifiants

pubmed: 31863551
doi: 10.1111/crj.13137
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

328-334

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Références

Ewig S. Community-acquired pneumonia: definition, epidemiology, and outcome. Semin Respir Infect. 1999;14(2):94-102.
Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med. 2003;138(2):109-118.
Ramirez JA, Wiemken TL, Peyrani P, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017;65(11):1806-1812.
Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med. 1995;333(24):1618-1624.
Aston SJ. Pneumonia in the developing world: characteristic features and approach to management. Respirology. 2017;22(7):1276-1287.
Ezzati M, Kammen DM. Indoor air pollution from biomass combustion and acute respiratory infections in Kenya: an exposure-response study. Lancet. 2001;358(9282):619-624.
Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013;68(11):1057-1065.
Garcia-Vidal C, Fernández-Sabé N, Carratalà J, et al. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J. 2008;32(3):733-739. https://doi.org/10.1183/09031936.00128107.
Cillóniz C, Ewig S, Ferrer M, et al. Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care. 2011;15(5):R209.
Phua J, Dean NC, Guo Q, Kuan WS, Lim HF, Lim TK. Severe community-acquired pneumonia: timely management measures in the first 24 hours. Crit Care. 2016;20(1):237.
Gupta D, Agarwal R, Aggarwal AN, et al. Pneumonia guidelines working group. Lung India. 2012;29(Suppl 2):S27-S62.
Khadanga S, Karuna T, Thatoi PK, Behera SK. Changing bacteriological profile and mortality trends in community acquired pneumonia. J Glob Infect Dis. 2014;6(4):186-188.
Irfan M, Hussain SF, Mapara K, et al. Community acquired pneumonia: risk factors associated with mortality in a tertiary care hospitalized patients. J Pak Med Assoc. 2009;59(7):448.
Raza MZ, Ahmed A, Ahmed F, Ghani A, Rizvi N. Seasonal incidence of community acquired pneumonia and its mortality in Karachi-A multi-centric hospital based study. Int J Environ Sci. 2012;3(2):885.
Khawaja A, Zubairi ABS, Durrani FK, Zafar A. Etiology and outcome of severe community acquired pneumonia in immune competent adults. BMC Infect Dis. 2013;13(1):94.
Song JH, Oh WS, Kang CI, et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents. 2008;31(2):107-114.
Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009; 64(Suppl 3):1-55.
Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-382.
Tudose C, Moisoiu A, Bogdan M. Mortality risk and etiologic spectrum of community-acquired pneumonia in hospitalized adult patients. Maedica (Buchar). 2010;5(4):258-264.
Shah BA, Singh G, Naik MA, Dhobi GN. Bacteriological and clinical profile of community acquired pneumonia in hospitalized patients. Lung India. 2010;27:54-57. https://doi.org/10.4103/0970-2113.63606.
Garau J, Baquero F, Perez-Trallero E, et al. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect. 2008;14:322-329.
Quah J, Jiang B, Tan PC, Siau C, Tan TY. Impact of microbial Aetiology on mortality in severe community-acquired pneumonia. BMC Infect Dis. 2018;18(1):451. https://doi.org/10.1186/s12879-018-3366-4.
Voiriot G, Visseaux B, Cohen J, et al. Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia. Crit Care. 2016;20(1):375.
Simonetti AF, Viasus D, Garcia-Vidal C, Carratalà J. Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis. 2014;2(1):3-16.
Jeon K, Yoo H, Jeong BH, et al. Functional status and mortality prediction in community-acquired pneumonia. Respirology. 2017;22(7):1400-1406. https://doi.org/10.1111/resp.13072.
Viasus D, Cillóniz C, Cardozo CG, et al. Early, short and long-term mortality in community-acquired pneumonia. Ann Res Hosp. 2018;2:5. https://doi.org/10.21037/arh.2018.04.02.
Uematsu H, Kunisawa S, Sasaki N, Ikai H, Imanaka Y. Development of a risk-adjusted in-hospital mortality prediction model for community-acquired pneumonia: a retrospective analysis using a Japanese administrative database. BMC Pulm Med. 2014;14:203. https://doi.org/10.1186/1471-2466-14-203.
Neupane B, Walter SD, Krueger P, Marrie T, Loeb M. Predictors of in-hospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study. BMC Geriatr. 2010;11(10):22. https://doi.org/10.1186/1471-2318-10-22.
Reade MC, Weissfeld L, Angus DC, Kellum JA, Milbrandt EB. The prevalence of anemia and its association with 90-daymortality in hospitalized community-acquired pneumonia. BMC Pulm Med. 2010;16(10):15. https://doi.org/10.1186/1471-2466-10-15.
Doshi SM, Rueda AM, Corrales-Medina VF, Musher DM. Anemia and community-acquired pneumococcal pneumonia. Infection. 2011;39:379-383.
Yadav D, Chandra J. Iron deficiency: beyond anemia. Indian J Pediatr. 2011;78:65-72. https://doi.org/10.1007/s12098-010-0129-7.
Chakrabarti B, Wootton D, Lane S, et al. The association between pre-hospital antibiotic therapy and subsequent in-hospital mortality in adults presenting with community-acquired pneumonia: an observational study. Pneumonia. 2018;25(10):2. https://doi.org/10.1186/s41479-018-0047-4.

Auteurs

Nousheen Iqbal (N)

Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.
Department of Medicine, Jinnah Medical and Dental College, Karachi, Pakistan.

Muhammad Irfan (M)

Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.

Faraz Siddique (F)

Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.

Verda Arshad (V)

Aga Khan University, Karachi, Pakistan.

Ali Bin Sarwar Zubairi (ABS)

Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH